RENEU (A Study to Evaluate the Safety, Effectiveness, and To

Name: RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)
Uploaded: 2025-03-24T21:12:33+00:00
Duration: 5 min 28 s
Description: Christopher Moertel, MD, Medical Director of the Pediatric Neuro-Oncology and Neurofibromatosis Programs at the University of Minnesota provides an overvie

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Neuroimaging After Brain Radiotherapy and Radiosurgery
Neuroimaging After Brain Radiotherapy and Radiosurgery
Imaging & Testing
Neuroimaging After Brain Radiotherapy and Radiosurgery
Venkatesh Shankar Madhugiri, MBBS, MCh, FACS; Neil D. Almeida, MD
Venkatesh Shankar Madhugiri, MBBS, MCh, FACS; Neil D. Almeida, MD
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Alzheimer Disease & Dementias
Special Report: 2025 Neurology FDA Drug & Device Approvals & Clearances
Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
Neuro-oncology
Modern Glioma Management: Integrating Molecular Markers and New Targeted Therapies
Patrick Y. Wen, MD
Patrick Y. Wen, MD
Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
Neuro-oncology
Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
Enmanuel J. Perez, MD, PhD; Garrett Camps, BEng, MD
Enmanuel J. Perez, MD, PhD; Garrett Camps, BEng, MD

PODCASTS

VIDEOS

COLUMNS

MEDICAL NEWS

MEETING COVERAGE

SPONSORED CONTENT

RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)

Recommended

RENEU (A Study to Evaluate the Safety, Effectiveness, and Tolerability of Gomekli in Children Aged ≥2 Years and Adults with an Inoperable NF1-PN; NCT03962543)

Recommended

Title